Adalimumab: a new modality for Behcet's disease?

Jan van Laar, T Missotten, Paul van Daele, A Jamnitski, GS Baarsma, P.M. van Hagen

Research output: Contribution to journalArticleAcademicpeer-review

86 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)565-566
Number of pages2
JournalAnnals of the Rheumatic Diseases
Volume66
Issue number4
DOIs
Publication statusPublished - 2007

Research programs

  • EMC MM-02-72-02

Cite this